• Revolution Medicines Price Target Raised to $235.00/Share From $205.00 by Guggenheim Moomoo Thu, 09 Jul 2026 20:17:09 GMT
• (rvmd) price dynamics and execution-aware positioning Stock Traders Daily Thu, 09 Jul 2026 19:20:01 GMT
• RVMD Maintained by Guggenheim -- Price Target Raised to $235 GuruFocus Thu, 09 Jul 2026 15:17:28 GMT
• ‘Pharma Bro’ Martin Shkreli Defends Revolution Medicines’ Pancreatic Cancer Study Data: ‘Progress Compounds’ Stocktwits Thu, 09 Jul 2026 14:01:00 GMT
• Revolution Medicines (RVMD) Wins Faster Reviews, Is The Valuation Already Too Rich? simplywall.st Wed, 08 Jul 2026 20:28:20 GMT
• Revolution Medicines Says EMA Begins Phased Review of Daraxonrasib for Pancreatic Cancer as FDA NDA Submission Nears Completion Quiver Quantitative Tue, 07 Jul 2026 13:31:00 GMT
• European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process Yahoo Finance Tue, 07 Jul 2026 13:23:00 GMT
• EMA fast-tracks Revolution Medicines' pancreatic cancer drug review Stock Titan Tue, 07 Jul 2026 13:23:00 GMT
• Revolution Medicines wins EU fast track review for cancer drug Seeking Alpha Tue, 07 Jul 2026 13:18:11 GMT
• EMA fast-tracks review of Revolutions’ experimental pancreatic cancer pill PharmaLive Tue, 07 Jul 2026 13:10:06 GMT
• EMA fast-tracks review of Revolutions' experimental pancreatic cancer pill Reuters Tue, 07 Jul 2026 13:09:42 GMT
• EMA fast tracks review of a medicine for metastatic pancreatic cancer European Medicines Agency (EMA) Tue, 07 Jul 2026 12:30:00 GMT
• Pulling the plug on cancer: Agios Pharmaceuticals, Revolution Medicines, and Vidac Pharma Stockhouse Tue, 07 Jul 2026 05:43:41 GMT
• ‘pharma bro’ martin shkreli defends revolution medicines’ pancreatic cancer study data: ‘progress compounds’ Stocktwits Tue, 07 Jul 2026 04:54:42 GMT
• Revolution Medicines: A $40 Billion Bet on a Cancer Breakthrough, But At What Price? Kavout | AI Mon, 06 Jul 2026 18:25:10 GMT
• Revolution Medicines stock hits all-time high at 193.12 USD Investing.com Mon, 06 Jul 2026 14:36:39 GMT
• UBS Maintains Revolution Medicines(RVMD.US) With Buy Rating, Raises Target Price to $220 Moomoo Mon, 06 Jul 2026 13:31:00 GMT
• h.c. wainwright maintains revolution medicines(rvmd.us) with buy rating, maintains target price $195 Moomoo Mon, 06 Jul 2026 13:31:00 GMT
• mizuho raises price target on revolution medicines to $215 from $185, keeps outperform rating Moomoo Mon, 06 Jul 2026 13:00:33 GMT
• Will Strong Early Zoldonrasib Pancreatic Data Change Revolution Medicines' (RVMD) RAS-Focused Narrative? simplywall.st Mon, 06 Jul 2026 11:28:11 GMT
• Revolution Medicines Is Up Nearly 140% in 2026. Is the Hot Biotech Stock Still a Buy? The Motley Fool Mon, 06 Jul 2026 00:15:00 GMT
• Revolution Medicines Is Up Nearly 140% in 2026. Is the Hot Biotech Stock Still a Buy? AOL.com Sun, 05 Jul 2026 23:35:00 GMT
• Revolution Medicines, Inc. Warrant Financial Disclosures & SEC Filings TradingView Sun, 05 Jul 2026 07:11:07 GMT
• revolution medicines reports encouraging early data for zoldonrasib combinations in ras g12d pancreatic cancer The Pharma Letter Fri, 03 Jul 2026 18:32:46 GMT
• Revolution’s RAS inhibitor pipeline posts more pancreatic cancer trial wins Clinical Trials Arena Fri, 03 Jul 2026 10:45:16 GMT
• Why Revolution Medicines (RVMD) Is Up 6.2% After Early Zoldonrasib Pancreatic Cancer Data And What's Next Yahoo Finance Fri, 03 Jul 2026 08:15:05 GMT
• Revolution Medicines Reports 82% Response Rate for Zoldonrasib in Metastatic Pancreatic Cancer The Clinical Trial Vanguard Fri, 03 Jul 2026 06:53:51 GMT
• Revolution Medicines (RVMD) Reports Positive Zoldonrasib Trial Data Ahead Of Phase 3 Yahoo Finance Fri, 03 Jul 2026 04:30:00 GMT
• Revolution Medicines (RVMD) Reports Phase 1 2 Pancreatic Cancer Data That Sets Up Phase 3 simplywall.st Fri, 03 Jul 2026 02:41:30 GMT
• Revolution Medicines sees large block trade worth $196.7 million Investing.com Thu, 02 Jul 2026 18:45:52 GMT
• revolution medicines director sushil patel sells $1.05m in stock by investing.com Investing.com Australia Thu, 02 Jul 2026 18:45:29 GMT
• revolution medicines reports zoldonrasib pancreatic cancer data grafa.com Thu, 02 Jul 2026 16:39:00 GMT
• Revolution Medicines shares promising data around KRAS drug combination Endpoints News Thu, 02 Jul 2026 15:30:00 GMT
• Revolution Medicines reports trial results for pancreatic cancer drug Investing.com Thu, 02 Jul 2026 12:50:30 GMT
• Revolution Medicines Presents Phase 1/2 Clinical Data for GlobeNewswire Thu, 02 Jul 2026 12:00:00 GMT
• Revolution Medicines shows 82% response in pancreatic cancer combo trial Stock Titan Thu, 02 Jul 2026 07:00:00 GMT
• ‘a watershed moment’: revolution medicines chief development officer dr. alan sandler on the breakthrough giving new hope in pancr... MSN Thu, 02 Jul 2026 00:41:02 GMT
• Revolution Medicines director Sushil Patel sells $1.05m in stock Investing.com Wed, 01 Jul 2026 23:04:55 GMT
• form 4 revolution medicines inc for: 1 july by investing.com Investing.com Canada Wed, 01 Jul 2026 22:36:48 GMT
• revolution medicines (nasdaq: rvmd) director sells 5,580 shares, exercises options Stock Titan Wed, 01 Jul 2026 22:25:32 GMT
• price to sales forward of revolution medicines, inc. – nasdaq:rvmd TradingView Wed, 01 Jul 2026 15:12:13 GMT
• oncology drugs fast-tracked by the fda in may and june 2026 Oncology News Central Wed, 01 Jul 2026 12:24:43 GMT
• Revolution Medicines Has a $40 Billion Market Cap and Generates No Revenue. Here's Why That's Not Absurd. The Motley Fool Wed, 01 Jul 2026 07:00:00 GMT
• price to earnings forward of revolution medicines, inc. – bmv:rvmd TradingView Wed, 01 Jul 2026 05:29:32 GMT
• enterprise value to revenue forward of revolution medicines, inc. – nasdaq:rvmd TradingView Tue, 30 Jun 2026 20:24:16 GMT
• Standing Ovation for the Undruggable: How Revolution Medicines Changed the Story of Pancreatic Cancer – Exclusive Interview Oncodaily Tue, 30 Jun 2026 19:25:59 GMT
• price to earnings forward of revolution medicines, inc. – mil:1rvmd TradingView Tue, 30 Jun 2026 10:43:09 GMT
• revolution medicines, inc.(nasdaqgs:rvmd) added to russell small cap comp growth benchmark marketscreener.com Mon, 29 Jun 2026 21:08:17 GMT
• proposed sale of rvmd common shares reported (nasdaq: rvmd) Stock Titan Mon, 29 Jun 2026 20:45:32 GMT
• price to sales forward of revolution medicines, inc. – mil:1rvmd TradingView Mon, 29 Jun 2026 15:55:00 GMT
• revolution medicines, inc. (rvmd) stock analysis: unraveling a $38.71 billion biotechnology powerhouse's growth potential DirectorsTalk Interviews Mon, 29 Jun 2026 09:25:50 GMT
• Revolution Medicines Price Target Raised to $235.00/Share From $183.00 by Needham Moomoo Mon, 29 Jun 2026 07:00:00 GMT
• revolution medicines, inc.(nasdaqgs: rvmd) added to russell 1000 growth benchmark marketscreener.com Mon, 29 Jun 2026 06:59:04 GMT
• revolution medicines, inc.(nasdaqgs:rvmd) dropped from russell 1000 value benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• revolution medicines, inc.(nasdaqgs: rvmd) dropped from russell 2500 index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• revolution medicines, inc.(nasdaqgs: rvmd) added to russell 3000 growth benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• enterprise value to ebitda forward of revolution medicines, inc. – nasdaq:rvmd TradingView Sun, 28 Jun 2026 14:45:25 GMT
• ‘pharma bro’ martin shkreli defends revolution medicines’ pancreatic cancer study data: ‘progress compounds’ Stocktwits Sat, 27 Jun 2026 12:31:43 GMT
• “maybe the best thing that happened is that didn’t work out”: alan sandler on daraxonrasib Oncodaily Sat, 27 Jun 2026 08:06:58 GMT
• insider sell: jack anders sells 20,000 shares of revolution medi GuruFocus Sat, 27 Jun 2026 04:18:45 GMT
• insider sell: jack anders sells 20,000 shares of revolution medi GuruFocus Fri, 26 Jun 2026 22:23:58 GMT
• revolution medicines (rvmd) cfo trades 20k shares under 10b5-1 plan Stock Titan Fri, 26 Jun 2026 20:10:35 GMT
• revolution medicines faces 'uphill battle' in potential patent claim against erasca, rbc says Moomoo Fri, 26 Jun 2026 15:40:44 GMT
• rbc capital maintains revolution medicines(rvmd.us) with buy rating, maintains target price $182 Moomoo Fri, 26 Jun 2026 12:33:00 GMT
• revolution medicines, inc. actuals & estimates (nasdaq:rvmd) TradingView Fri, 26 Jun 2026 10:49:57 GMT
• anirban maitra: revolution medicines is out with a preclinical study evaluating rmc-8839 Oncodaily Thu, 25 Jun 2026 23:49:39 GMT
• revolution medicines, inc. stock 12‑month price target raised to $188.57, implies 11% upside TradingView Thu, 25 Jun 2026 19:20:05 GMT
• bofa securities maintains revolution medicines(rvmd.us) with buy rating, raises target price to $212 富途牛牛 Thu, 25 Jun 2026 14:32:00 GMT
• j.p. morgan maintains revolution medicines(rvmd.us) with buy rating, announces target price $200 富途牛牛 Thu, 25 Jun 2026 14:02:09 GMT
• truist financial maintains revolution medicines(rvmd.us) with buy rating Moomoo Thu, 25 Jun 2026 12:31:00 GMT
• ‘a watershed moment’: revolution medicines chief development officer dr. alan sandler on the breakthrough giving new hope in pancr... MSN Thu, 25 Jun 2026 07:47:08 GMT
• Revolution’s second RAS blocker doubles chemo response rate in pancreatic cancer BioSpace Thu, 25 Jun 2026 07:00:00 GMT
• How Launching a Pivotal RAS G12D Pancreatic Cancer Trial At Revolution Medicines (RVMD) Has Changed Its Investment Story simplywall.st Thu, 25 Jun 2026 07:00:00 GMT
• Revolution Medicines rises as investors focus on fresh pancreatic cancer pipeline updates Quiver Quantitative Thu, 25 Jun 2026 07:00:00 GMT
• Revolution Medicines to Present Clinical Data from RAS(ON) GlobeNewswire Wed, 24 Jun 2026 23:31:08 GMT
• form 144 revolution medicines for: 24 june by investing.com Investing.com Nigeria Wed, 24 Jun 2026 21:41:29 GMT
• a pancreatic cancer drug provides new hope: five things to know about daraxonrasib Stanford Medicine Wed, 24 Jun 2026 21:29:39 GMT
• form 144 | revolution medicines(rvmd.us) officer proposes to sell 3.39 million in common stocks Moomoo Wed, 24 Jun 2026 20:36:42 GMT
• enterprise value to ebit forward of revolution medicines, inc. – nasdaq:rvmd TradingView Wed, 24 Jun 2026 19:32:58 GMT
• 'a watershed moment': revolution medicines chief development officer dr. alan sandler on the breakthrough giving new hope in pancr... SurvivorNet Wed, 24 Jun 2026 17:49:34 GMT
• enterprise value to revenue forward of revolution medicines, inc. – tradegate:42z TradingView Wed, 24 Jun 2026 14:49:55 GMT
• rvmd starts treatment in phase iii pancreatic cancer study on zoldonrasib Yahoo Finance Wed, 24 Jun 2026 14:13:00 GMT
• after apogee, 3 more biotech buyout targets wall street can’t stop watching 24/7 Wall St. Wed, 24 Jun 2026 11:55:10 GMT
• revolution medicines begins treating patients in rasolute 305, a phase 3 clinical trial evaluating zoldonrasib in combination with... Sahm Wed, 24 Jun 2026 07:26:28 GMT
• Revolution Medicines to Present Four RAS(ON) Pipeline Studies at 2026 ESMO Gastrointestinal Cancers Congress Quiver Quantitative Wed, 24 Jun 2026 07:00:00 GMT
• Jack Anders (RVMD) files to sell 20,000 shares after option exercise Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• revolution medicines puts pancreatic cancer combo data on esmo stage Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• revolution medicines opens rasolute 305 trial of zoldonrasib in ras g12d pancreatic cancer The Clinical Trial Vanguard Wed, 24 Jun 2026 06:52:59 GMT
• form 4 revolution medicines inc for: 23 june by investing.com Investing.com Nigeria Tue, 23 Jun 2026 22:16:50 GMT
• revolution medicines (rvmd) initiates phase 3 trial for pancreatic cancer treatment GuruFocus Tue, 23 Jun 2026 20:11:10 GMT
• revolution medicines begins phase 3 pancreatic cancer trial grafa.com Tue, 23 Jun 2026 16:40:00 GMT
• Revolution Medicines begins phase 3 trial for pancreatic cancer Investing.com Tue, 23 Jun 2026 07:00:00 GMT
• Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with... GlobeNewswire Tue, 23 Jun 2026 07:00:00 GMT
• Revolution Medicines (RVMD) Stock Could Be 24% Overvalued After RASolute 302 Trial Data simplywall.st Tue, 23 Jun 2026 07:00:00 GMT
• Revolution Medicines (RVMD) grants stock options and RSUs to director Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Revolution Medicines opens Phase 3 pancreatic cancer trial with zoldonrasib Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Revolution Medicines (RVMD) director receives new stock and option grants Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Revolution Medicines (RVMD) director granted RSUs and stock options in latest Form 4 Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• revolution medicines (nasdaq: rvmd) director receives stock and 3,127-share option grant Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• revolution medicines (rvmd) director receives stock awards and options grant Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• revolution medicines' pdac revenue could rise up to 40% on positive doublet data, ubs says marketscreener.com Mon, 22 Jun 2026 15:38:15 GMT
• revolution medicines: alan sandler, chief development officer, to continue to oversee the company's development department; jan sm... Moomoo Mon, 22 Jun 2026 13:07:12 GMT
• revolution medicines to implement updated leadership structure for r&d functions, effective july 1 >rvmd Moomoo Mon, 22 Jun 2026 12:01:00 GMT
• revolution medicines announces planned leadership transition for steve kelsey, m.d. Yahoo! Finance Canada Mon, 22 Jun 2026 12:00:00 GMT
• revolution medicines, inc. (rvmd) stock analysis: a biotech powerhouse with 14.91% potential upside DirectorsTalk Interviews Mon, 22 Jun 2026 09:19:20 GMT
• Revolution Medicines reshapes R&D as Kelsey plans retirement Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• revolution medicines announces leadership transition in r&d Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• revolution medicines (nasdaq: rvmd) details kelsey transition and 2026 shareholder vote outcomes Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• revolution medicines stock hits all-time high at 166.64 usd Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• revolution medicines: steve kelsey, pres, r&d, to transition to senior advisor to ceo ahead of planned retirement in jan 2027 >rvm... Moomoo Mon, 22 Jun 2026 07:00:00 GMT
• revolution medicines (rvmd) stock could be 24% overvalued after rasolute 302 trial data Sahm Mon, 22 Jun 2026 07:00:00 GMT
• the cancer drugmakers pulling ahead—and what they’re building next geneonline.com Mon, 22 Jun 2026 05:18:23 GMT
• le laboratoire pharmaceutique spécialisé dans le cancer revolution medicines affirme que sa vente n'est pas une priorité - ft TradingView Sun, 21 Jun 2026 04:08:00 GMT
• cancer drugmaker revolution medicines says sale not a priority - ft TradingView Sun, 21 Jun 2026 04:07:58 GMT
• Cancer drugmaker Revolution Medicines says sale not a priority Financial Times Sat, 20 Jun 2026 07:00:00 GMT
• revolution medicines, azienda produttrice di farmaci antitumorali, afferma che la vendita non è una priorità - ft TradingView Sat, 20 Jun 2026 07:00:00 GMT
• florida man dying as mark cuban, brian mast urge cancer drug release Treasure Coast News Fri, 19 Jun 2026 07:00:00 GMT
• revolution medicines officer sold shares worth over $720k TradingView Thu, 18 Jun 2026 20:20:01 GMT
• verastem deprioritizes pancreatic cancer work after ‘decent, but not great’ data shadowed by revolution BioSpace Thu, 18 Jun 2026 12:02:26 GMT
• revolution medicines inc (rvmdw) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 11:20:18 GMT
• why is revolution medicines (rvmd) up 9.3% since last earnings report? MSN Thu, 18 Jun 2026 08:34:10 GMT
• revolution medicines (rvmd) director sells 10,020 shares in rule 10b5-1 tax sale Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• revolution medicines (rvmd) counsel sells 2,157 shares under 10b5-1 plan Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• [form 4] revolution medicines, inc. insider trading activity Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• revolution medicines (rvmd) officer sells 4,175 shares under 10b5-1 plan Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• revolution medicines (rvmd) executive executes automatic tax sale after rsu vesting Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• revolution medicines’ anthony mancini sells $720,490 in stock Investing.com Thu, 18 Jun 2026 07:00:00 GMT
• the secret mechanism that kills cancer cells: what revolution medicines and merck & co. need to learn from vidac pharma news.financial Thu, 18 Jun 2026 05:35:00 GMT
• revolution medicines inc (rvmdw) institutional confidence TradingKey Thu, 18 Jun 2026 03:30:47 GMT
• revolution medicines inc (rvmdw) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 23:33:27 GMT
• revolution medicines inc (rvmd) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 17:50:29 GMT
• revolution medicines (rvmd) coo trades options, sells 93,575 shares under 10b5-1 Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• revolution medicines inc (rvmdw) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 06:47:47 GMT
• revolution drug doubles pancreatic cancer survival, ignites korea race - chosunbiz Chosunbiz Tue, 16 Jun 2026 21:01:00 GMT
• ‘pharma bro’ martin shkreli defends revolution medicines’ pancreatic cancer study data: ‘progress compounds’ Stocktwits Tue, 16 Jun 2026 16:54:14 GMT
• revolution medicines (rvmd) is up 7.8% after phase 3 survival data validates ras(on) strategy simplywall.st Tue, 16 Jun 2026 09:42:51 GMT
• revolution medicines inc (rvmd) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• revolution medicines (nasdaq: rvmd) affiliate reports sale of 2,958 shares under rule 144 Stock Titan Mon, 15 Jun 2026 22:23:21 GMT
Revolution Medicines, Inc(NASDAQ:RVMD) 
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gyne...
Website: http://www.revmed.com
Founded: 2014
Full Time Employees: 117
CEO: Mark A. Goldsmith
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends